Oğuzhan Kayhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oğuzhan Kayhan has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Oktay Demirkıran
İstanbul Üniversitesi-Cerrahpaşa
4 shared publications - Ahmet Furkan Kurt
Department of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
2 shared publications - Bilgul Mete
Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey
2 shared publications - Gökhan Aygün
Department of Medical Microbiology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey
2 shared publications - Süha Bozbay
Department of Anesthesiology and Reanimation, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, İstanbul, Türkiye
2 shared publications - Abdurrahman Kaya
Department of Infectious Diseases and Clinical Microbiology, İstanbul Training and Research Hospital, İstanbul, Türkiye
1 shared publication
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in Scientific Reports
Frailty, organ dysfunction and mortality in older ICU patients
- 25 August 2026
- Published by Springer Nature in Scientific Reports
Open AccessFrailty, organ dysfunction and mortality in older ICU patients
- Open Access
- 28 June 2025
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 38 (2) , 62-96
Use of Procalcitonin and C-Reactive Protein in the Diagnosis and Treatment of Infectious Diseases: National Consensus Report
Levels of C-reactive protein (CRP), an acute-phase protein, and procalcitonin (PCT) in serum and certain body fluids increase during inflammatory conditions, particularly bacterial infections, and decrease following treatment or resolution of the triggering cause. Therefore, both biomarkers can be effectively utilized for diagnosing infectious diseases, differentiating between viral and bacterial infections, monitoring antibiotic treatment response, and making decisions regarding the cessation of therapy. In recent years, with the significant global and national increase in antimicrobial resistance, these biomarkers have become increasingly important as part of antimicrobial stewardship practices promoting rational antimicrobial use. This consensus report aims to guide the optimal utilization of CRP and PCT in managing infectious diseases in adult patients across various clinical settings and patient groups based on a review of the current literature and collaboration among seven relevant medical societies. We hope this report will benefit all physicians involved in diagnosing and treating adult infectious diseases.
- 28 June 2025
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 38 (2) , 62-96
Open AccessUse of Procalcitonin and C-Reactive Protein in the Diagnosis and Treatment of Infectious Diseases: National Consensus Report
Levels of C-reactive protein (CRP), an acute-phase protein, and procalcitonin (PCT) in serum and certain body fluids increase during inflammatory conditions, particularly bacterial infections, and decrease following treatment or resolution of the triggering cause. Therefore, both biomarkers can be effectively utilized for diagnosing infectious diseases, differentiating between viral and bacterial infections, monitoring antibiotic treatment response, and making decisions regarding the cessation of therapy. In recent years, with the significant global and national increase in antimicrobial resistance, these biomarkers have become increasingly important as part of antimicrobial stewardship practices promoting rational antimicrobial use. This consensus report aims to guide the optimal utilization of CRP and PCT in managing infectious diseases in adult patients across various clinical settings and patient groups based on a review of the current literature and collaboration among seven relevant medical societies. We hope this report will benefit all physicians involved in diagnosing and treating adult infectious diseases.
- Open Access
- 26 February 2025
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 23 (1) , 61-69
Potential Drug-Drug Interaction Detection Using the UpToDate Mobile Application in Intensive Care: A Retrospective, Observational Study
Amaç Bu çalışmada UpToDate ilaç etkileşimleri uygulaması ile potansiyel ilaç-ilaç etkileşimlerinin (PİİE) sıklığı ve kullanılan ilaç sayısının PİİE üzerindeki etkisinin araştırılması amaçlandı. Gereç ve Yöntem Çalışmaya 2016 yılında 3 gün ve daha fazla yoğun bakım ünitesinde tedavi gören 12 yaş üstü hastalar dahil edildi. 24 saatten fazla kullanılan ilaçların UpToDate uygulamasına girilmesiyle PİİE’ler tespit edildi. Hafif, orta ve ağır PİİE toplam sayısı ile kullanılan ilaç sayısı, kalış süresi, yaş, kronik hastalık sayısı, mekanik ventilasyon (MV) desteği, hastaneye yatış tanıları ve APACHE II skoru istatistiksel olarak karşılaştırıldı. Bulgular Uygulanan ilaç sayısı arttıkça PİİE’nin arttığı bulunurken, hastanede yatış gün sayısı ile kesin bir ilişki göstermediği belirlendi. Ancak MV desteği alan, APACHE II skoru yüksek olan ve ölen hastalarda bu oran daha yüksekti. PİİE en az postoperatif takip tanı grubunda görüldü. Sonuç Kritik hastalarda kullanılan ilaç sayısı arttıkça PİİE’nin arttığı belirlendi.
- 26 February 2025
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 23 (1) , 61-69
Open AccessPotential Drug-Drug Interaction Detection Using the UpToDate Mobile Application in Intensive Care: A Retrospective, Observational Study
Amaç Bu çalışmada UpToDate ilaç etkileşimleri uygulaması ile potansiyel ilaç-ilaç etkileşimlerinin (PİİE) sıklığı ve kullanılan ilaç sayısının PİİE üzerindeki etkisinin araştırılması amaçlandı. Gereç ve Yöntem Çalışmaya 2016 yılında 3 gün ve daha fazla yoğun bakım ünitesinde tedavi gören 12 yaş üstü hastalar dahil edildi. 24 saatten fazla kullanılan ilaçların UpToDate uygulamasına girilmesiyle PİİE’ler tespit edildi. Hafif, orta ve ağır PİİE toplam sayısı ile kullanılan ilaç sayısı, kalış süresi, yaş, kronik hastalık sayısı, mekanik ventilasyon (MV) desteği, hastaneye yatış tanıları ve APACHE II skoru istatistiksel olarak karşılaştırıldı. Bulgular Uygulanan ilaç sayısı arttıkça PİİE’nin arttığı bulunurken, hastanede yatış gün sayısı ile kesin bir ilişki göstermediği belirlendi. Ancak MV desteği alan, APACHE II skoru yüksek olan ve ölen hastalarda bu oran daha yüksekti. PİİE en az postoperatif takip tanı grubunda görüldü. Sonuç Kritik hastalarda kullanılan ilaç sayısı arttıkça PİİE’nin arttığı belirlendi.
- Open Access
- 24 December 2024
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 22 (4) , 264-269
Workplace Violence Against Turkish Intensive Care Physicians: A Cross-sectional Study
Amaç Yer, zaman, kişi fark etmeksizin herkese yönelebilen şiddeti, giderek artan sıklıkta yaşayan sağlık çalışanlarından olan yoğun bakım hekimlerinin tecrübe ve görüşlerinin alınması amaçlandı. Gereç ve Yöntem Yirmi sekiz çoktan seçmeli ve açık uçlu sorudan oluşan anketin ülke çapında yoğun bakım hekimlerinin yanıtlaması sağlandı. Bulgular %44’ü erkek, %56’sı kadın olan 198 hekimin yanıtladığı online anket çalışmasında, hekimlerin %86’sının çalıştığı hastanede şiddet olayı yaşandığı, %47’sinin ise yoğun bakımda çalıştıkları süre boyunca şiddete maruz kaldıkları tespit edildi. Gerçekleşen şiddetin %62 oranıyla en fazla sözel tehdit olduğu, %30 oranında ise fiziksel şiddet olduğu görüldü. Şiddete uğrayanlar en fazla hastane güvenliğini aramayı (%56) tercih ettiğini belirtti. Yaşanan şiddet olaylarının %65’inin konuşarak çözüldüğü tespit edildi. Şiddete maruz kalanların ve tüm hekimlerin çok büyük çoğunluğunun ortak görüşünün tedbirlerin yetersizliği ve şiddet olaylarının tekrarlayacağı şeklindeydi. Sonuç Tüm dünyada ve ülkemizde sağlıkta şiddet artış göstermektedir. Alınması gereken önlemler hastalara ve yakınlarına yönelik olduğu gibi sağlık çalışanlarına ve sağlık sisteminin kendisine yönelik de olmalıdır.
- 24 December 2024
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 22 (4) , 264-269
Open AccessWorkplace Violence Against Turkish Intensive Care Physicians: A Cross-sectional Study
Amaç Yer, zaman, kişi fark etmeksizin herkese yönelebilen şiddeti, giderek artan sıklıkta yaşayan sağlık çalışanlarından olan yoğun bakım hekimlerinin tecrübe ve görüşlerinin alınması amaçlandı. Gereç ve Yöntem Yirmi sekiz çoktan seçmeli ve açık uçlu sorudan oluşan anketin ülke çapında yoğun bakım hekimlerinin yanıtlaması sağlandı. Bulgular %44’ü erkek, %56’sı kadın olan 198 hekimin yanıtladığı online anket çalışmasında, hekimlerin %86’sının çalıştığı hastanede şiddet olayı yaşandığı, %47’sinin ise yoğun bakımda çalıştıkları süre boyunca şiddete maruz kaldıkları tespit edildi. Gerçekleşen şiddetin %62 oranıyla en fazla sözel tehdit olduğu, %30 oranında ise fiziksel şiddet olduğu görüldü. Şiddete uğrayanlar en fazla hastane güvenliğini aramayı (%56) tercih ettiğini belirtti. Yaşanan şiddet olaylarının %65’inin konuşarak çözüldüğü tespit edildi. Şiddete maruz kalanların ve tüm hekimlerin çok büyük çoğunluğunun ortak görüşünün tedbirlerin yetersizliği ve şiddet olaylarının tekrarlayacağı şeklindeydi. Sonuç Tüm dünyada ve ülkemizde sağlıkta şiddet artış göstermektedir. Alınması gereken önlemler hastalara ve yakınlarına yönelik olduğu gibi sağlık çalışanlarına ve sağlık sisteminin kendisine yönelik de olmalıdır.
- 1 October 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (1) , 22-28
Donor Care
- 1 October 2023
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 21 (1) , 22-28
Donor Care
- 31 December 2020
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 2 (3) , 181-183
Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19
Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an
- 31 December 2020
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 2 (3) , 181-183
Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19
Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an
- Open Access
- 16 December 2019
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 43 (3) , 92-96
Enteral Nutrition Target of Critical Patients in The Intensive Care Unit
Objective: Nutritional support (NS) is an important part of the treatment of patients in the intensive care unit (ICU). The preferred method for NS is enteral nutrition (EN). The aim of the present study was to investigate the time of initiation of NS for patients admitted in the ICU, whether the nutritional target dose was achieved and if not, the factors that led to this. Methods: The study was planned retrospectively and included patients aged between 18 and 90 years, followed up between 01/01/2017 and 12/31/2018 in the emergency ICU. Patients’ demographic characteristics, the time of nutritional supplementation initiation, the time of achieving the target, and EN termination reasons during the nutritional status were evaluated. Results: A total of 152 patients were analyzed. Of the 152 patients, 49 were investigated for enteral feeding. Enteral NS was provided via nasogastric tube (93%) and percutaneous endoscopic gastrostomy (PEG) (7%). The mean time to start EN was 10.3 (±8.6) h. The mean time to reach the target was 14.1 (±5.9) h in 96% of the patients. In 2 patients, the target dose could not be reached due to vomiting and excess gastric residual volume. Thirty (61%) patients had problems during NS and EN interrupted. Conclusion: Any critically ill patient who has been in intensive care for >48 h should be considered at risk for malnutrition. In patients undergoing intensive care, it is recommended to start enteral feeding within 48 h (early enteral feeding) if there is no oral intake. Cite this article as: Aktaş H, Bozbay S, Kayhan O, Demirkıran O. Enteral Nutrition Target of Critical Patients in The Intensive Care Unit. Cerrahpasa Med J 2019; 43(3): 92-96.
- 16 December 2019
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 43 (3) , 92-96
Open AccessEnteral Nutrition Target of Critical Patients in The Intensive Care Unit
Objective: Nutritional support (NS) is an important part of the treatment of patients in the intensive care unit (ICU). The preferred method for NS is enteral nutrition (EN). The aim of the present study was to investigate the time of initiation of NS for patients admitted in the ICU, whether the nutritional target dose was achieved and if not, the factors that led to this. Methods: The study was planned retrospectively and included patients aged between 18 and 90 years, followed up between 01/01/2017 and 12/31/2018 in the emergency ICU. Patients’ demographic characteristics, the time of nutritional supplementation initiation, the time of achieving the target, and EN termination reasons during the nutritional status were evaluated. Results: A total of 152 patients were analyzed. Of the 152 patients, 49 were investigated for enteral feeding. Enteral NS was provided via nasogastric tube (93%) and percutaneous endoscopic gastrostomy (PEG) (7%). The mean time to start EN was 10.3 (±8.6) h. The mean time to reach the target was 14.1 (±5.9) h in 96% of the patients. In 2 patients, the target dose could not be reached due to vomiting and excess gastric residual volume. Thirty (61%) patients had problems during NS and EN interrupted. Conclusion: Any critically ill patient who has been in intensive care for >48 h should be considered at risk for malnutrition. In patients undergoing intensive care, it is recommended to start enteral feeding within 48 h (early enteral feeding) if there is no oral intake. Cite this article as: Aktaş H, Bozbay S, Kayhan O, Demirkıran O. Enteral Nutrition Target of Critical Patients in The Intensive Care Unit. Cerrahpasa Med J 2019; 43(3): 92-96.
- 17 July 2019
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 47 (4) , 301-306
The Effects of Locally Administered Morphine Over the Dura on Postoperative Morphine Consumption and Pain After Lumbar Disc Surgery: A Prospective, Randomised, Double-Blind and Placebo-Controlled Study
Effective pain management by avoiding side effects in the perioperative period is essential for patient outcome. Lumbar disc surgery is associated with moderate to severe postoperative pain, and opioids are widely used. The primary aim of the present study was to compare the effects of 1 mg and 2 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura on morphine consumption, and the secondary aims were to compare pain scores and opioid-related side effects during postoperative 24 h. The study included 44 patients (American Society of Anesthesiologists I and II). After the discectomy procedure and before the closure, in Group A (n=15), 1 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura was used. In Group B (n=14), 2 mg morphine was used for the same technique, and in Group C (n=15) (control), normal saline was used. All patients used intravenous morphine patient-controlled analgesia pumps for 24 h following lumbar disc surgery. Morphine consumption, pain scores and opioid-related side effects were recorded at 10 min, 1, 2, 6, 12 and 24 h postoperatively. Morphine consumption, pain scores and opioid-related side effects were similar among the groups. Morphine-impregnated absorbable cellulose haemostat material placement over the dura after single level lumbar discectomy did not reduce postoperative morphine consumption, pain scores and incidence of opioid-related side effects.
- 17 July 2019
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 47 (4) , 301-306
The Effects of Locally Administered Morphine Over the Dura on Postoperative Morphine Consumption and Pain After Lumbar Disc Surgery: A Prospective, Randomised, Double-Blind and Placebo-Controlled Study
Effective pain management by avoiding side effects in the perioperative period is essential for patient outcome. Lumbar disc surgery is associated with moderate to severe postoperative pain, and opioids are widely used. The primary aim of the present study was to compare the effects of 1 mg and 2 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura on morphine consumption, and the secondary aims were to compare pain scores and opioid-related side effects during postoperative 24 h. The study included 44 patients (American Society of Anesthesiologists I and II). After the discectomy procedure and before the closure, in Group A (n=15), 1 mg morphine-impregnated absorbable cellulose haemostat material placed over the dura was used. In Group B (n=14), 2 mg morphine was used for the same technique, and in Group C (n=15) (control), normal saline was used. All patients used intravenous morphine patient-controlled analgesia pumps for 24 h following lumbar disc surgery. Morphine consumption, pain scores and opioid-related side effects were recorded at 10 min, 1, 2, 6, 12 and 24 h postoperatively. Morphine consumption, pain scores and opioid-related side effects were similar among the groups. Morphine-impregnated absorbable cellulose haemostat material placement over the dura after single level lumbar discectomy did not reduce postoperative morphine consumption, pain scores and incidence of opioid-related side effects.